RaptIvapml.com
About RaptIvapml.com
The U.S. Food and Drug Administration is investigating the psoriasis drug Raptiva for a possible link to a rare, but often deadly, brain infection called progressive multifocal leukoencephalopathy (PML). At least two people have died and others may also have developed PML while taking Raptiva, made by Genentech. Raptiva has also been associated with meningitis, immune-mediated hemolytic anemia, and other life-threatening infections.
